15h
Hosted on MSNvivo joins NBA in welcoming NBA All-Star 2025For the second consecutive year, vivo returns as the Official Presenting Partner of NBA All-Star Voting in the Philippines.
Vivo is set to launch the T4x 5G in India soon with details about its expected launch timeline, price, battery size, and ...
We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...
Noise has expanded its audio line-up with the new Noise Airwave Max 5 Headphones, following its predecessor, Noise Airwave Max 4. These headphones feature an ergonomic design with sophisticated ...
Vivo launched a couple of top-tier phones for the global market at the tailend of 2024 — the premium Vivo X200 Pro and the almost-identical Vivo X200. Both of them are equipped with flagship-grade ...
Xiaomi has announced in China that it has started recruiting Xiaomi Pad 6S Pro 12.4 users internally from the Xiaomi Community to test a new WinPlay engine in HyperOS that will let you play Windows ...
vivo’s flagship line, the X series is finally back in the Philippines. And despite the strong competition from bigger names in the industry, vivo managed to put out a great smartphone that can go ...
As part of the recently announced portfolio reorganization, NTLA is planning to prioritize the development of its late-stage programs — NTLA-2002 and nexiguran ziclumeran (nex-z). The company ...
where 27 out of 28 participants that received the ex vivo gene therapy were free from presenting the occlusion of blood vessels, with a mean 9.5 months being vaso occlusion-free. Despite ...
The ultrawide camera also uses a 50MP sensor, though it's a smaller Type 1/2.88 (5.0 x 3.7mm) model, attached to an F2 lens that provides a 122° field of view. However, it does show that the company ...
With vivo and Huawei growing (by 14% and 24%, respectively), both were breathing down Apple’s neck – both companies shipped 12.9 million units in Q4. For 2025, the analysts expect the ...
Cash, cash equivalents and investments at year-end 2024 were approximately $9.5 billion ... its investigational in vivo genome-editing candidate, Nexiguran ziclumeran (nex-z, also known as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results